Evidence for transforming growth factor-beta 3 gene polymorphism in non-syndromic cleft lip and palate patients from indian sub-continent

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 17, Issue 2, 2012, Pages 197-200

  Shaikh, Saleem ^a   Ravenndranath, Rajendran ^b   Banerjee, Moinak ^c   Joseph, Anna ^d   Jahgirdar, Pramod ^e  

^a ACPM Dental College   (India)

^b Government Dental College   (India)

^c RAJIV GANDHI CENTRE FOR BIOTECHNOLOGY   (India)

^d PMS College of Dental Sciences   (India)

^e Seema Dental College and Hospital   (India)

Author keywords

Gene polymorphism; Nonsyndromic cleft lip with without cleft palate; Orofacial clefts; Polymerase chain reaction; TGF 3

Indexed keywords

DNA; TRANSFORMING GROWTH FACTOR BETA3;

BLOOD SAMPLING; CASE CONTROL STUDY; CLEFT LIP PALATE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; GENETIC POLYMORPHISM; HUMAN; INDIAN; INFORMED CONSENT; POLYMERASE CHAIN REACTION; REVIEW;

CLEFT LIP; CLEFT PALATE; HUMANS; INDIA; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84857854784     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.17453     Document Type: Review

References (26)

1. Mitchell LE, Christensen K. Analysis of the recurrence patterns for nonsyndromic cleft lip with or without cleft palate in the families of 3,073 Danish probands. Am J Med Genet. 1996;61:371-6.
2. Hecht JT, Yang P, Michels VV, Buektow KH. Complex segregation analysis of nonsyndromic cleft lip and palate. Am J Hum Genet. 1991;49:674-81.
3. Wong FK, Hagberg C, Karsten A, Larson O, Gustavsson M, Huggare J, et al. Linkage analysis of candidate regions in Swedish nonsyndromic cleft lip with or without cleft palate families. Cleft Palate Craniofac J. 2000;37:357-62.
4. Brunet CL, Sharpe PM, Ferguson MW. Inhibition of TGF-beta 3 (but not TGF-beta 1 or TGF-beta 2) activity prevents normal mouse embryonic palate fusion. Int J Dev Biol. 1995;39:345-55.
5. Vieira AR, Orioli IM, Castilla EE, Cooper ME, Marazita ML, Murray JC. MSX1 and TGFB3 contribute to clefting in South America. J Dent Res. 2003;82:289-92.
6. Dudas M, Nagy A, Laping NJ, Moustakas A, Kaartinen V. Tgf-beta3-induced palatal fusion is mediated by Alk-5/Smad pathway. Dev Biol. 2004;266:96-108.
7. Kim MH, Kim HJ, Choi JY, Nahm DS. Transforming growth factor-beta 3 gene SfaN1 polymorphism in Korean nonsyndromic cleft lip and palate patients. J Biochem Mol Biol. 2003;36:533-7.
8. Sun D, Vanderburg CR, Odierna GS, Hay ED. TGFbeta3 promotes transformation of chicken palate medial edge epithelium to mesenchyme in vitro. Development. 1998;125:95-105.
9. Taya Y, O'Kane S, Ferguson MW. Pathogenesis of cleft palate in TGF-beta3 knockout mice. Development. 1999;126:3869-79.
10. Murray JC. Face facts: genes, environment, and clefts. Am J Hum Genet.1995;57:227-32.
11. Fraser FC. The genetics of cleft lip and cleft palate. Am J Hum Genet.1970;22:336-52.
12. Schutte BC, Murray JC. The many faces and factors of orofacial clefts. Hum Mol Genet. 1999;8:1853-9.
13. Ferguson MW. Palate development. Development. 1988;103Suppl:41-60.
14. Ferguson WJ. Epithelial-mesenchymal interactions during vertebrate palatogenesis. Curr Top Dev Biol. 1984;19:137-64.
15. Kaartinen V, Cui XM, Heisterkamp N, Groffen J, Shuler CF. Transforming growth factor-beta3 regulates transdifferentiation of medial edge epithelium during palatal fusion and associated degradation of the basement membrane. Dev Dyn. 1997;209:255-60.
16. Tudela C, Formoso MA, Martínez T, Pérez R, Aparicio M, Maestro C, et al. TGF-beta3 is required for the adhesion and intercalation of medial edge epithelial cells during palate fusion. Int J Dev Biol. 2002;46:333-6.
17. Martinez-Alvarez C, Tudela C, Perez-Miguelsanz J, O'Kane S, Puerta J, Ferguson MW. Medial edge epithelial cell fate during palatal fusion. Dev Biol. 2000;220:343-57.
18. Kohama K, Nonaka K, Hosokawa R, Shum L, Ohishi M. TGF-beta-3 promotes scarless repair of cleft lip in mouse fetuses. J Dent Res. 2002;81:688-94.
19. Proetzel G, Pawlowski SA, Wiles MV, Yin M, Boivin GP, Howles PN, et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet. 1995;11:409-14.
20. Tyler MS, Koch WE. In vitro development of palatal tissues from embryonic mice. III. Interactions between palatal epithelium and heterotypic oral mesenchyme. J Embryol Exp Morphol. 1977;38:37-48.
21. Baroni T, Carinci P, Bellucci C, Lilli C, Becchetti E, Carinci F, et al. Cross-talk between interleukin-6 and transforming growth factor-beta3 regulates extracellular matrix production by human fibroblasts from subjects with non-syndromic cleft lip and palate. J Periodontol. 2003;74:1447-53.
22. Lidral AC, Murray JC, Buetow KH, Basart AM, Schearer H, Shiang R, et al. Studies of the candidate genes TGFB2, MSX1, TGFA, and TGFB3 in the etiology of cleft lip and palate in the Philippines. Cleft Palate Craniofac J. 1997;34:1-6.
23. Tanabe A, Taketani S, Endo-Ichikawa Y, Tokunaga R, Ogawa Y, Hiramoto M. Analysis of the candidate genes responsible for non-syndromic cleft lip and palate in Japanese people. Clin Sci (Lond). 2000;99:105-11.
24. Jugessur A, Lie RT, Wilcox AJ, Murray JC, Taylor JA, Saugstad OD, et al. Variants of developmental genes (TGFA, TGFB3, and MSX1) and their associations with orofacial clefts: a case-parent triad analysis. Genet Epidemiol. 2003;24:230-9.
25. Hagberg, C, Larson O, Milerad J. Incidence of cleft lip and palate and risks of additional malformations. Cleft Palate Craniofac J. 1998;35:40-5.
26. Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J Cell Sci. 1995;108:985-1002.